K. Altundag Et Al. , "Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue," MEDICAL HYPOTHESES , vol.67, no.1, pp.202-203, 2006
Altundag, K. Et Al. 2006. Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue. MEDICAL HYPOTHESES , vol.67, no.1 , 202-203.
Altundag, K., Silay, Y. S., Altundag, O., Atik, M. A., & Aktolga, S., (2006). Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue. MEDICAL HYPOTHESES , vol.67, no.1, 202-203.
Altundag, Kadri Et Al. "Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue," MEDICAL HYPOTHESES , vol.67, no.1, 202-203, 2006
Altundag, Kadri Et Al. "Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue." MEDICAL HYPOTHESES , vol.67, no.1, pp.202-203, 2006
Altundag, K. Et Al. (2006) . "Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue." MEDICAL HYPOTHESES , vol.67, no.1, pp.202-203.
@article{article, author={Kadri Altundag Et Al. }, title={Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue}, journal={MEDICAL HYPOTHESES}, year=2006, pages={202-203} }